
- BioPharm International-09-15-2017
- Volume 2017 eBook
- Issue 2
Patenting Prospects for Cell-Based Therapies
Cell-based therapies are moving medical treatments forward, but intellectual property uncertainties may delay progress.
Treatment using cell-based therapies involves significant investment and, therefore, can be expected to have concomitantly significant costs to patients and their insurers. Accordingly, patent exclusivity will be important to defray high development and regulatory compliance costs.
The nature of such therapies, and recent patent law trends regarding natural products and methods relating to the practice of medicine, suggest these therapies may not be given the type of robust patent protection conventionally available for small-molecule drugs. The author discusses the impact of patent considerations for cell-based therapies.
Download the
.
Article Details
BioPharm Internationalâ¨eBook: Development Strategies for Emerging Therapies
Vol. 30
September 2017
Pages: 19–22
Citation
When referring to this article, please cite it as K. Noonan, " Patenting Prospects for Cell-Based Therapies," BioPharm International Development Strategies for Emerging Therapies eBook (September 2017).
Articles in this issue
about 8 years ago
Harvest of Human Mesenchymal Stem Cells from Microcarriersabout 8 years ago
End-to-End Cell Therapy Automation: An Immunotherapy Case Studyabout 8 years ago
Optimizing a Unique Cancer Vaccine for Intradermal Deliveryabout 8 years ago
Accelerating Genetic Medicine R&D Using Microfluidicsabout 8 years ago
Overcoming Hurdles in Emerging Therapy DevelopmentNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.